United Kingdom· GB-APID-3725411000001102
Neostigmine 15mg tablets
A neostigmine product containing neostigmine, registered in United Kingdom by Alliance Pharmaceuticals Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Neostigmine is registered in 10 of 19 countries.
Countries holding a registration under ATC N07AA01 (neostigmine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Neostigmine · ATC N07AA01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Neostigmine
- Manufacturer
- Alliance Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- N07AA01
- ATC class
- Neostigmine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5024403000240
- gtin5036631009070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
68 interactions on record for neostigmine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Neostigmine · interactions on record
68 records
- 6 severe
- 62 moderate
Most severe, free to view
- SiponimodL04AA42severe
- SiponimodL04AE03severe
- BupropionN06AX12severe
- BupropionN07BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Neostigmine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSYNTOSTIGMINZentiva, k.s., Praha
- Japanネオスチグミンメチル硫酸塩
- SpainNEOSTIGMINA BRAUN 0,5 MG/ML SOLUCIÓN INYECTABLEB Braun Medical S.A.
- FrancePROSTIGMINE 0,5 mg/1 ml, solution injectableVIATRIS MEDICAL
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Syntostigmin
- Romania · Neostigmină Lph Labormed
- Slovakia · Syntostigmin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa9d1b88-68f4-4373-96e0-28b52f29c6ad GET /v1/drugs/aa9d1b88-68f4-4373-96e0-28b52f29c6ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3725411000001102",
"desc": "Neostigmine 15mg tablets (Alliance Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "42038311000001108",
"source": "dmd",
"vtm_id": "776891001",
"strength": "15 mg",
"substance": "Neostigmine",
"ingredient": "Neostigmine bromide",
"supplier_code": "3417301000001102"
}See everything about neostigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.